Cargando…
Generalizability in two clinical trials of Lyme disease
OBJECTIVE: To examine the generalizability of two National Institutes of Health (NIH)-funded double-blind randomized placebo-controlled clinical trials in patients with chronic Lyme disease and to determine whether selection factors resulted in the unfavorable outcomes. DESIGN: Epidemiologic review...
Autor principal: | Cameron, Daniel J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1626453/ https://www.ncbi.nlm.nih.gov/pubmed/17044928 http://dx.doi.org/10.1186/1742-5573-3-12 |
Ejemplares similares
-
Are verbatim transcripts necessary in applied qualitative research: experiences from two community-based intervention trials in Ghana
por: Hill, Zelee, et al.
Publicado: (2022) -
Lyme disease: the next decade
por: Stricker, Raphael B, et al.
Publicado: (2011) -
Discovery of the Lyme Disease Agent
por: Barbour, Alan G., et al.
Publicado: (2019) -
The role of sexually transmitted infections in male circumcision effectiveness against HIV – insights from clinical trial simulation
por: Desai, Kamal, et al.
Publicado: (2006) -
Enhancing access to reports of randomized trials published world-wide – the contribution of EMBASE records to the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library
por: Lefebvre, Carol, et al.
Publicado: (2008)